Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Guruprasad Padsalgi"'
Autor:
Cyriac Abby Philips, Rajaguru Paramaguru, Philip Augustine, Sasidharan Rajesh, Rizwan Ahamed, Tom George, Guruprasad Padsalgi
Publikováno v:
Hepatology Communications, Vol 3, Iss 7, Pp 1001-1012 (2019)
Drug‐induced liver injury (DILI) due to complementary and alternative medicine (CAM) use is on the rise throughout the world by patients looking for “safer” alternatives. However, data on acute‐on‐chronic liver failure (ACLF) due to CAM are
Externí odkaz:
https://doaj.org/article/4d4cdabc4e0440c1accccdb181f32697
Autor:
Rajaguru Paramaguru, Pushpa Mahadevan, Thomas J. George, Philip Augustine, Cyriac Abby Philips, Guruprasad Padsalgi, Sasidharan Rajesh, Rizwan Ahamed
Publikováno v:
Journal of Clinical and Translational Hepatology
We repurposed the antifibrotic drug pirfenidone—which is approved for treatment of idiopathic lung fibrosis—in a series of patients with nonalcoholic steatohepatitis-related cirrhosis. Our report demonstrates the observed improvements in necroinf
Autor:
Philip Augustine, Karthik Ganesan, Cyriac Abby Philips, Solomon K. John, Nikhil Phadke, Gopakumar C. Valiathan, Sasidharan Rajesh, Guruprasad Padsalgi, Rizwan Ahamed
Publikováno v:
J Clin Exp Hepatol
Background Alcoholic hepatitis (AH) is associated with gut dysbiosis. Comparative gut microbial profiles of acute alcoholic pancreatitis (AAP) and acute biliary disease (ABD) are not demonstrated. We aimed to compare gut microbiota of AH, AAP, and AB
Autor:
Philip Augustine, Cyriac Abby Philips, Rajaguru Paramaguru, Rizwan Ahamed, Tom George, Sasidharan Rajesh, Guruprasad Padsalgi
Publikováno v:
Hepatology Communications, Vol 3, Iss 7, Pp 1001-1012 (2019)
Hepatology Communications
Hepatology Communications
Drug‐induced liver injury (DILI) due to complementary and alternative medicine (CAM) use is on the rise throughout the world by patients looking for “safer” alternatives. However, data on acute‐on‐chronic liver failure (ACLF) due to CAM are
Publikováno v:
Hepatic Medicine: Evidence and Research. 11:23-34
Portosystemic shunt (PS) syndrome encompasses a spectrum of disease manifestations ranging from asymptomatic portal hypertension to recurrent and refractory hepatic encephalopathy, ultimately culminating in progressive hepatic failure in patients of
Autor:
Rajaguru Paramaguru, Rizwan Ahamed, Cyriac Abby Philips, Guruprasad Padsalgi, Philip Augustine
Publikováno v:
Cureus
We present the rare case of a young male with sinusoidal obstruction syndrome due to Ayurvedic herbal medicine which he took for management of bilateral leg swelling associated with protein-losing enteropathy due to intestinal lymphangiectasia. The p
Autor:
Rajaguru Paramaguru, Cyriac Abby Philips, Philip Augustine, Guruprasad Padsalgi, Tom George, Sasidharan Rajesh, Rizwan Ahamed, Gopakumar C. Valiathan, Solomon K. John
Publikováno v:
J Clin Exp Hepatol
Background Granulocyte colony-stimulating factor (GCSF) has been utilized in decompensated cirrhosis (DC) for improving transplant-free survival (TFS). Data from multiple centers are conflicting with regard to patient outcomes. In this retrospective
Autor:
Sasidharan Rajesh, Cyriac Abby Philips, Guruprasad Padsalgi, Rizwan Ahamed, Nikhil Phadke, Meenal Agarwal, Philip Augustine
Publikováno v:
J Clin Exp Hepatol
Familial cirrhosis is a condition that is associated with the presence of liver disease with genetic linkage among multiple family members in a generation or in multiple generations. With cirrhosis, most of these disease pathogeneses are related to a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::245a53edc6aa3c7f3bcc0f58d6eae66b
https://europepmc.org/articles/PMC6823681/
https://europepmc.org/articles/PMC6823681/
Publikováno v:
Hepatitis Monthly.
Autor:
Philip Augustine, Rizwan Ahamed, Sasidharan Rajesh, Amal Jose, Cyriac Abby Philips, Guruprasad Padsalgi
Publikováno v:
Journal of hepatology. 70(3)